Riliprubart granted orphan drug designation in Japan for chronic inflammatory demyelinating polyneuropathy  Two phase 3 studies are currently underway testing riliprubart in people with CIDP as a ...

Paris: Sanofi has received orphan drug designation from the Ministry of Health, Labour and Welfare (MHLW) in Japan for ...

Riliprubart granted orphan drug designation in Japan for chronic inflammatory demyelinating polyneuropathy. Two phase 3 studies are currently underway testing riliprubart in peopl ...

Riliprubart granted orphan drug designation in Japan for chronic inflammatory demyelinating polyneuropathy Two phase 3 ...

OBJECTIVES To investigate the incidence of hyperreflexia in patients with Guillain-Barré syndrome (GBS), and its relation with electrodiagnosis of acute motor axonal neuropathy (AMAN), antiganglioside ...

A team of physicians recently reported the successful treatment of refractory autoimmune neuropathies through the infusion of ...

Multifocal motor neuropathy (MMN) is a rare disease that causes slowly worsening muscle weakness, mainly in your hands, arms, and legs. It affects your body's motor nerves, which control your muscles.

Demyelinating optic neuritis is often a herald of multiple sclerosis, but it is only one of the many neuro-ophthalmologic abnormalities which may present in MS.

Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that argenx received European Commission (EC) approval of VYVGART® 1000mg (efgartigimod alfa) developed with ENHANZE ...

At Health from Within, a 4-pronged protocol has been developed to help patients heal from neuropathy without the need for prescription medications or invasive procedures.

Discover how CBD products may help relieve neuropathy and nerve pain. Learn about the latest research on their effectiveness, safety, and how to use them.